Fentanyl Market Segmented by Oral, Intravenous, Intramuscular, Subcutaneous, Epidural administration, Intrathecal administration, Transdermal Patch used in Indication such as Pain Management, Auto-immune Disease, Cold and Cough, Diarrhoea
Industry: Healthcare
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Report Type: Ongoing
Report ID: PMRREP32416
Fentanyl is appropriate for a wide range of analgesia and pain after a medical procedure, gynaecology, and so on. Likewise it can be used to reduce or prevent hallucination after medical procedure. It can likewise be utilized along with sedating agent as an assistant medication. It is utilized with haloperidol to form "diazepam pain relieving", which is utilized for pain relieving of enormous minor operation and scale dressing change. Fentanyl is also recognized as a solid narcotic agent and is viewed as 100 times more effective in contrast with morphine.
The development of fentanyl market is estimated to be boosted by expansion in incidences of cancer pain, chronic pain, increase in prescription for fentanyl, and popularity for OTC non-narcotic or analgesic prescriptions. Additionally, their utilization in the administration of chronic pain is viewed as standard practice in many places worldwide. Because of an expansion in the load of clinical illnesses, the fentanyl market is relied upon to develop over the conjecture time frame.
The worldwide fentanyl market is driven by increase in patient pool encountering cancer pain, chronic pain, expanded interest for OTC non-narcotics, and low costs of analgesics. Additionally, Increase in geriatric populace is probably going to impel the occurrence pace of constant infections, like malignancy, diabetes, and bone-related issues, as older individuals are at a more serious danger of these sicknesses, which will thusly prompt market development. This occurrence of persistent diseases around the world is making significant wellbeing trouble on most economies. As indicated in 2019, by the International Journal of Immunopathology and Pharmacology, occurrence of neuropathic pain in general people was assessed to be between 3% - 17% around the world. Pain relieving treatment is the backbone for muscular treatment of patients with moderate to serious pain, which will expand interest for fentanyl.
Besides, expanding number of medical procedures is likewise expected to support development of the market. Also, analgesics assume a critical part in present post-operative care on give satisfactory pain relief. According to the Center for Disease Control and Prevention, in 2020, above 32.5 million people in the United States were influenced by osteoarthritis.
Increase in the amount of patients experiencing terminally ongoing diseases, for example, severe cough coming about because of a cancer, HIV and lung disease and high flood in the use of analgesics after post-operative medical procedures are factors expected to help utilization of fentanyl as analgesics. The NHPCO (National Hospice and Palliative Care Organization) is the biggest non-profit organization (NPO) leading palliative consideration programs and hospice in NORTH AMERICA As indicated by NHPCO, around 36.6% out of the patients conceded to palliative care centers were experiencing disease, and the remaining (63.4%) were experiencing non-malignancy conditions. This exhibits the likely utilization of narcotics in non-prescription conditions during palliative consideration. In addition, expanding number of medical procedures is additionally expected to support development of the market. For example, in 2020, as indicated by Plastic Surgery Statistics Report by The American Society of Plastic Surgeons, assessed 4.3 million cosmetic surgeries were done in 2020, in the U.S.
The utilization of fentanyl may prompt adverse effects like sedation, vomiting, constipation, nausea, urinary retention, and falls, which is projected to hamper development of the worldwide fentanyl market. Additionally, expanding instances of opioid overdose cases is likewise anticipated to hinder development of the market. For instance, worldwide 0.5 million deaths occur due to drug overdose.
Fentanyl abuse is a serious problem related to the drug usage. Fentanyl analogs manufactured in illegal labs might be 100 times more powerful than road heroin and will in general create fundamentally more respiratory depression, making them much more risky to clients than heroin. Additionally, withdrawal indications related with fentanyl treatment which generally begin within 12 hours of the last portion of fentanyl and can most recent last a week or more which hampers the fentanyl market development.
Based on Route of Administration, the Fentanyl market has been segmented as:
Based on Indication, the Fentanyl market has been segmented as:
Based on Distribution Channel, the Fentanyl market has been segmented as:
The major players present in the market are
North American stands firm on the main foothold in the Fentanyl market. Demand for fentanyl is rising in the North America due to increasing prevalence rate of chronic diseases and high consumption of fentanyl as a pain reliever as well as for abusive use. The North America is majorly focused on branded opioid manufacturers interested in launching novel products to maintain compliance with updated regulatory guidelines. Moreover, governmental support for ongoing clinical research has allowed the North America to dominate the pain management landscape.
After North America, Europe is the second most lucrative region in the market. The Europe healthcare system is a universal and well-renowned system, largely funded by the government. It is one of the most successful healthcare systems in the world. It is not surprising that the Europe has the highest level of spending. According to our analysis, the Europe is identified as the third-leading market, and the position is likely to hold through the forecast period. Furthermore, rising research efforts, increasing pipeline drugs, and presence of several major players creates a huge opportunity for fentanyl in the country.
Asia Pacific nations are the following most quickly filling on the lookout. As of late, small and large pharmaceutical organizations have vigorously put resources into research zones and R&D tasks. Fentanyl interest is probably going to develop, as most items in the pipeline are going to arrive at the end stage, and would be accessible before the decade is over. It is simpler to select patients for clinical trials in emerging countries. Clinical trials and research have become a significant business in India because of factors, for example, presence of government-supported drug and clinical establishments with developed facilities, which aids in as ideal place for clinical trials. Cost of R&D is considerably less in India when contrasted with that in developed nations.
Key market players adopt product launches and approval strategies to expand their presence and product portfolio globally and satisfy the growing demand. Funding and assistance that is provided by governmental as well as non-governmental groups such as WHO will boost the market growth. Furthermore, the increase in advanced research activities for the discovery and developments of novel technological advancements would be the major benefit for global players.
Also, the Rising reimbursements in almost globally is also growing the market. Moreover, expansion to enlarge customer base is one of the major strategies of the key companies worldwide, which also permits the players to maintain their brand name globally.
Rising investment towards research and development activities in regions like North America and Europe is expected to create a large number of opportunities for global Fentanyl market growth. The shift of lifestyle patterns towards unhealthy lifestyle is expected to increase patient suffering from various diseases such as cancer, diabetes, lung diseases, HIV and others creating large customer based for global Fentanyl market due to rise in number of surgeries.
The increasing number of domestic players in countries like India will lead to a rise in production capacity and growth for global Fentanyl market. Moreover, key companies are increasing their investments in research and development activities for the discovery of novel drugs. There has also been an increase in the expenditure of government towards healthcare sector for the introduction of new Fentanyl market. Additionally, creating potential and commercial formulations with increased potency and efficacy adaptations are anticipated to offer potential opportunities to major companies manufacturing fentanyl.
The pandemic is tossing an enormous unfavourable effect on the Fentanyl market. Biopharmaceutical and medical services enterprises in general were hit by this pandemic test in 2020. The inventory network interference and monetary effect of the pandemic on the little, and medium-sized endeavours likewise unfavourably influenced the Fentanyl market development. As the bringing in was ended, this has antagonistically influenced the funds of most of drug organizations. The deficiency of labour because of COVID19 pandemic hamper in innovative work just as business creation of biologics everywhere on the world which is additionally the central point colossally affect the Fentanyl market development in 2020.
The wellbeing emergency worldwide has shown an exceptional impact on organizations across all the ventures. However, this is viewed as a transient impact, be that as it may, the developing help from governments and central members can help in the battle against this Covid pandemic. Besides, it is seen that a few ventures that are battling and some are thriving. All around the world, each section is anticipated to be affected by the pandemic In the light of COVID-19 pandemic, there is a greater demand for various types of treatment related surgeries for cancer, diabetes, lung diseases and others. These factors will ultimately rise the need of this drug and drive the global Fentanyl market.
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.
To know more about delivery timeline for this report Contact Sales
